EBAA Comments on FDA Guidances
EBAA submitted comments to FDA last week on recent guidances that address HCT/P donor eligibility and recommendations to reduce the risk of HIV, hepatitis B virus and hepatitis C virus […]
EBAA submitted comments to FDA last week on recent guidances that address HCT/P donor eligibility and recommendations to reduce the risk of HIV, hepatitis B virus and hepatitis C virus […]
BACKGROUND Several recent FDA inspections of eye banks have resulted in Form FDA 483, Inspectional Observations, for not determining donors to be ineligible with a diagnosis of sepsis. All cited […]
Dylan TurnerThe Cincinnati Eye Bank Recovery Technician EBAA has long advocated for reducing or eliminating FDA’s 5-year exclusionary period for cornea donation for MSM. Navigating a system that was designed […]
On Friday, May 26, Medscape published the article, “Advocates Expect the FDA to Ease Restrictions on Cornea Donation by Gay and Bisexual Men.” The article notes EBAA’s longtime support for […]
On May 5, EBAA alerted the membership about a critical supply issue with the BioRad HIV 1/2 Plus O EIA Assay through an All Member post in The Lens. Two […]
360 Partners enjoy year-round access to EBAA members